Page 21 - ESHRE2019

Drug discovery
Computational tools Library screening Bioactive molecule lead
Biological testing
Initial
hits hits
Molecule optimization
Refined
Animal models
Phase I Phase II Phase III
30% abandoned for lack of efficacy 30% abandoned for safety concerns
Phase IV
16
PRECONGRESS COURSE 13 I VIENNA, AUSTRIA – 23 JUNE 2019 19